Año: 2019
Journal Impact Factor (JIF): 17.1270
| Categoría | Edición | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|---|
| CLINICAL NEUROLOGY | SCIE | 3/204 | Q1 | T1 | D1 |
Año: 2019
Journal Citation Indicator (JCI): 3,610
| Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
|---|---|---|---|---|---|
| CLINICAL NEUROLOGY | 5/253 | Q1 | T1 | D1 | 98,22 |
Año:
2019
CiteScore:
21,100
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Cellular and Molecular Neuroscience | 4/84 | Q1 | T1 | D1 |
| Developmental Neuroscience | 1/33 | Q1 | T1 | D1 |
| Epidemiology | 4/93 | Q1 | T1 | D1 |
| Geriatrics and Gerontology | 1/96 | Q1 | T1 | D1 |
| Health Policy | 1/239 | Q1 | T1 | D1 |
| Neurology (clinical) | 4/348 | Q1 | T1 | D1 |
| Psychiatry and Mental Health | 7/506 | Q1 | T1 | D1 |
SJR año:
2019
Factor de Impacto:
6,012
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Cellular and Molecular Neuroscience | 3/97 | Q1 | T1 | D1 |
| Developmental Neuroscience | 1/41 | Q1 | T1 | D1 |
| Epidemiology | 6/128 | Q1 | T1 | D1 |
| Geriatrics and Gerontology | 1/116 | Q1 | T1 | D1 |
| Health Policy | 1/299 | Q1 | T1 | D1 |
| Neurology (clinical) | 3/410 | Q1 | T1 | D1 |
| Psychiatry and Mental Health | 7/610 | Q1 | T1 | D1 |
| Agencia | Código de Proyecto |
|---|---|
| - | PI13/02434; PI16/01861; PI17/01474 |
| AbbVie | - |
| Agencia IDEA (Consejeria de Innovacion, Junta de Andalucia) | - |
| AGES | N01-AG12100 |
| Alzheimer's Association | ADGC-10-196728 |
| Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) | U01 AG024904 |
| Alzheimer's Drug Discovery Foundation | - |
| Alzheimer's Research UK | 503176 |
| Araclon Biotech | - |
| Araclon Biotech S.A. | - |
| BioClinica, Inc. | - |
| Biogen | - |
| Biomedical Research Foundation | - |
| Bristol-Myers Squibb Company | - |
| Canadian Institutes of Health Research | - |
| CereSpir, Inc. | - |
| CIBER de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM) | - |
| Cogstate | - |
| Consejeria de Salud de la Junta de Andalucia | PI-0001/2017 |
| Corporacion Tecnologica de Andalucia | - |
| CurePSP Foundation | - |
| Diabetes Research Laboratory | - |
| DOD ADNI (Department of Defense) | W81XWH-12-2-0012 |
| Eisai Inc. | - |
| Elan Pharmaceuticals, Inc. | - |
| Eli Lilly and Company | - |
| Erasmus Medical Center and Erasmus University | - |
| EuroImmun | - |
| European Union/EFPIA Innovative Medicines Initiative Joint undertaking ADAPTED project | 115975 |
| European Union/EFPIA Innovative Medicines Initiative Joint undertaking MOPEAD project | 115985 |
| F. Hoffmann-La Roche Ltd | - |
| Fondo Europeo de Desarrollo Regional (FEDER-"Una manera de Hacer Europa") | - |
| French National Foundation on Alzheimer's disease and related disorders | - |
| Fujirebio | - |
| Fundacio ACE | - |
| Fundacion Alzheimur (Murcia) | - |
| Fundacion bancaria "La Caixa" | - |
| GE Healthcare | - |
| Genentech, Inc. | - |
| German Federal Ministry of Education and Research (BMBF): Competence Network Dementia (CND) | 01GI0102; 01GI0711; 01GI0420 |
| Grifols SA | - |
| Icelandic Heart Association | - |
| Illinois Department of Public Health | - |
| Inserm | - |
| Institut Pasteur de Lille | - |
| ISCIII (Instituto de Salud Carlos III)-Subdireccion General de Evaluacion | - |
| ISCIII (Ministry of Health, Spain) | - |
| IXICO Ltd. | - |
| Janssen Alzheimer Immunotherapy Research AMP; Development, LLC. | - |
| Johnson AMP; Johnson Pharmaceutical Research AMP; Development LLC. | - |
| Kronos Life Science Laboratories | - |
| LABEX (laboratory of excellence program investment for the future) DISTALZ grant | - |
| Laboratorios Echevarne | - |
| Lille University Hospital | - |
| Lumosity | - |
| Lundbeck | - |
| Mayo Clinic Alzheimer's Disease Center | P50 AG16574 |
| Mayo Foundation | - |
| Medical Research Council | 503480 |
| Merck Co., Inc. | - |
| Meso Scale Diagnostics, LLC. | - |
| Ministerio de Educacion y Ciencia (Gobierno de Espana) | - |
| National Alzheimer's Coordinating Center | U01 AG016976 |
| National Institute of Biomedical Imaging and Bioengineering | - |
| National Institute on Aging | - |
| National Institute on Aging (Arizona Alzheimer's Disease Center) | P30 AG19610; RO1 AG023193 |
| NeuroRx Research | - |
| Neurotrack Technologies | - |
| NHLBI | R01 HL105756 |
| NIA | P50 AG016574; R01 AG032990; U01 AG046139; R01 AG018023; U01 AG006576; U01 AG006786; R01 AG025711; R01 AG017216; R01 AG003949; P30AG10161; R01AG15819; R01AG17917; R01AG30146; R01AG36836; U01AG32984; U01AG46152; AG081220 |
| NIA Division of Neuroscience | U01-AG032984 |
| NIH/NIA | U01 AG016976; U01 AG032984; U24 AG021886; R01 AG033193 |
| NINDS | R01 NS080820 |
| Novartis Pharmaceuticals Corporation | - |
| Pfizer Inc. | - |
| Piramal AG | - |
| Piramal Imaging | - |
| Servier | - |
| SMEs as part of InnoMed (Innovative Medicines in Europe) - European Union of the Sixth Framework program priority FP6-2004-LIFESCIHEALTH-5 | - |
| state of Arizona | - |
| Takeda Pharmaceutical Company | - |
| Transition Therapeutics | - |
| Translational Genomics Research Institute | - |
| Trinitat Port-Carbo legacy | - |
| Universite de Lille 2 | - |
| Wellcome Trust | 082604/2/07/Z |
| # | Autor | Afiliación |
|---|---|---|
| 1 | Moreno-Grau, Sonia | Universitat Internacional de Catalunya; CIBER Enfermedades Neurodegenerativas (Spain) |
| 2 | de Rojas, Itziar | Universitat Internacional de Catalunya (Spain) |
| 3 | Hernández, Isabel | Universitat Internacional de Catalunya; CIBER Enfermedades Neurodegenerativas (Spain) |
| 4 | Quintela, Inés | Universidad de Santiago de Compostela (Spain) |
| 5 | Montrreal, Laura | Universitat Internacional de Catalunya (Spain) |
| 6 | Alegret, Montserrat | Universitat Internacional de Catalunya; CIBER Enfermedades Neurodegenerativas (Spain) |
| 7 | Hernández-Olasagarre, Begoña | Universitat Internacional de Catalunya (Spain) |
| 8 | Madrid, Laura | CAEBI (Spain) |
| 9 | González-Perez, Antonio | CAEBI (Spain) |
| 10 | Maroñas, Olalla | Universidad de Santiago de Compostela (Spain) |
| 11 | Rosende-Roca, Maitée | Universitat Internacional de Catalunya (Spain) |
| 12 | Mauleón, Ana | Universitat Internacional de Catalunya (Spain) |
| 13 | Vargas, Liliana | Universitat Internacional de Catalunya (Spain) |
| 14 | Lafuente, Asunción | Universitat Internacional de Catalunya (Spain) |
| 15 | Abdelnour, Carla | Universitat Internacional de Catalunya; CIBER Enfermedades Neurodegenerativas (Spain) |
| 16 | Rodríguez-Gómez, Octavio | Universitat Internacional de Catalunya; CIBER Enfermedades Neurodegenerativas (Spain) |
| 17 | Gil, Silvia | Universitat Internacional de Catalunya (Spain) |
| 18 | Santos-Santos, Miguel Ángel | Universitat Internacional de Catalunya (Spain) |
| 19 | Espinosa, Ana | Universitat Internacional de Catalunya; CIBER Enfermedades Neurodegenerativas (Spain) |
| 20 | Ortega, Gemma | Universitat Internacional de Catalunya; CIBER Enfermedades Neurodegenerativas (Spain) |
| 21 | Sanabria, Ángela | Universitat Internacional de Catalunya; CIBER Enfermedades Neurodegenerativas (Spain) |
| 22 | Pérez-Cordón, Alba | Universitat Internacional de Catalunya (Spain) |
| 23 | Cañabate, Pilar | Universitat Internacional de Catalunya; CIBER Enfermedades Neurodegenerativas (Spain) |
| 24 | Moreno, Mariola | Universitat Internacional de Catalunya (Spain) |
| 25 | Preckler, Silvia | Universitat Internacional de Catalunya (Spain) |
| 26 | Ruiz, Susana | Universitat Internacional de Catalunya; CIBER Enfermedades Neurodegenerativas (Spain) |
| 27 | Aguilera, Nuria | Universitat Internacional de Catalunya (Spain) |
| 28 | Pineda, Juan Antonio | Hospital Universitario de Valme (Spain) |
| 29 | Macías, Juan | Hospital Universitario de Valme (Spain) |
| 30 | Alarcón-Martín, Emilio | Universidad de Malaga; Universitat Internacional de Catalunya (Spain) |
| 31 | Sotolongo-Grau, Oscar | Universitat Internacional de Catalunya (Spain) |
| 32 | Marquié, M. | Universitat Internacional de Catalunya; National Institutes of Health (NIH) (United States) |
| 33 | Monté-Rubio, G. | Universitat Internacional de Catalunya; National Institutes of Health (NIH) (United States) |
| 34 | Valero, S. | Mutua de Terrassa (Spain) |
| 35 | Benaque, A. | Universitat Internacional de Catalunya (Spain) |
| 36 | Clarimón, J. | Sin datos () |
| 37 | Bullido, M. J. | Sin datos () |
| 38 | García-Ribas, G. | Sin datos () |
| 39 | Pástor, P. | Sin datos () |
| 40 | Sánchez-Juan, P. | Sin datos () |
| 41 | Álvarez, V. | Sin datos () |
| 42 | Piñol-Ripoll, G. | Sin datos () |
| 43 | García-Alberca, J. M. | Sin datos () |
| 44 | Royo, J. L. | Sin datos () |
| 45 | Franco, E. | Sin datos () |
| 46 | Mir, P. | Sin datos () |
| 47 | Calero, M. | Sin datos () |
| 48 | Medina, M. | Sin datos () |
| 49 | Rábano, A. | Sin datos () |
| 50 | Ávila, J. | Sin datos () |
| 51 | Antúnez, C. | Sin datos () |
| 52 | Real, L. M. | Sin datos () |
| 53 | Orellana, A. | Sin datos () |
| 54 | Carracedo, Á. | Sin datos () |
| 55 | Sáez, M. E. | Sin datos () |
| 56 | Tárraga, L. | Sin datos () |
| 57 | Boada, M. | Sin datos () |
| 58 | Sin datos () | |
| # | Autoría grupal | Afiliación |
| 1 | GR@ACE consortium | Sin datos () |
| 1 | DEGESCO consortium | Sin datos () |
| 3 | Alzheimer's disease neuroimaging initiative | Sin datos () |
| 4 | Labrador Espinosa MA (DEGESCO consortium) | Sin datos () |
| 5 | Periñán-Tocino, Teresa (DEGESCO consortium) | Sin datos () |
